The present invention provides metabolites of the antiviral drug bictegravir, including compositions and salts thereof, which are useful in the prevention and/or treatment of HIV as well as analytical methods related to the administration of bictegravir.
The present invention provides metabolites of the antiviral drug bictegravir, including compositions and salts thereof, which are useful in the prevention and/or treatment of HIV as well as analytical methods related to the administration of bictegravir.
[EN] METABOLITES OF BICTEGRAVIR<br/>[FR] MÉTABOLITES DU BICTÉGRAVIR
申请人:GILEAD SCIENCES INC
公开号:WO2019144015A1
公开(公告)日:2019-07-25
The present invention provides metabolites of the antiviral drug bictegravir, including compositions and salts thereof, which are useful in the prevention and/or treatment of HIV as well as analytical methods related to the administration of bictegravir.